Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS

Clinical trial NCT07095712 · COMPLETED

Trial details

NCT number: NCT07095712
Sponsor: n-Lorem Foundation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-11-25
Primary completion: 2025-12-16
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.